Michael Haude

A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study

Haude M, Wlodarczak A, van der Schaaf R, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth G, Joner M, Toelg R, Wiemer M, Olivecrano G, Vermeersch P, Garcia-Garcia H, Waksman R

August 7, 2023 | 10.4244/EIJ-D-23-00326

One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry

Wlodarczak A, Montorsi P, Torzewski J, Bennett J, Starmer G, Buck T, Haude M, Moccetti M, Wiemer M, Lee M, Verheye S

June 19, 2023 | 10.4244/EIJ-D-22-01069

Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds

Seguchi M, Baumann-Zumstein P, Fubel A, Waksman R, Haude M, Galli S, Joner M

June 5, 2023 | 10.4244/EIJ-D-22-00718

Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial

Slagboom T, Toelg R, Witzenbichler B, Haude M, Masotti M, Ruiz Salmeron R, Witkowski A, Uematus M, Takahashi A, Waksman R, Saito S

February 20, 2023 | 10.4244/EIJ-D-22-00526

EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology.

Van Belle E, Teles R, Pyxaras S, Kalpak O, Johnson T, Barbash I, De Luca G, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth G, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri Ferre J, Kammler J, Muir D, O'Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda R, Piróth Z, Wojakowski W, Geppert A, Di Gioia G, Pires-Morais G, Petronio A, Estevez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem NM, Windecker S, Baumbach A, Haude M, Dudek D

May 16, 2021 | 10.4244/EIJ-D-18-00448

Impact of clinical and haemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries: a patient-level pooled analysis of the DEBATE and ILIAS studies

Stegehuis V, Wijntjens G, Bax M, Meuwissen M, Chamuleau S, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys PW, Piek J, van de Hoef TP

April 2, 2021 | 10.4244/EIJ-D-19-00774

Computed tomography angiography imaging of the Carillon device topography after unsuccessful treatment of functional mitral regurgitation

Rottländer D, Gödde M, Degen H, Haude M

March 19, 2021 | 10.4244/EIJ-D-20-00332

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Serruys PW

December 4, 2020 | 10.4244/EIJ-D-20-00024

Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stents

Nicol P, Bulin A, Castellanos M, Stöger M, Obermeier S, Lewerich J, Lenz T, Hoppmann P, Baumgartner C, Fischer J, Steiger K, Haude M, Joner M

December 4, 2020 | 10.4244/EIJ-D-19-00747

Reply: Cardiac CT prior to percutaneous coronary sinus-based mitral annuloplasty with the Carillon device

Rottländer D, Gödde M, Degen H, Haude M

November 20, 2020 | 10.4244/EIJ-D-20-00621R

Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska JJ, de Winter R, Hamm C, Steg G, Stoll H, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys PW

October 23, 2020 | 10.4244/EIJ-D-19-00498

Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R

February 7, 2020 | 10.4244/EIJ-D-18-01000

Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry

Verheye S, Wlodarczak A, Montorsi P, Bennett J, Torzewski J, Haude M, Vrolix M, Buck T, Aminian A, van der Schaaf R, Nuruddin A, Lee M

February 7, 2020 | 10.4244/EIJ-D-18-01058

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Ruiz Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

Evolving paradigms in valvular heart disease: where should guidelines move?

Baumbach A, Dudek D, Baumgartner H, Windecker S, Haude M

November 15, 2019 | 10.4244/EIJ-D-19-00818

Coronary sinus to mitral valve annulus topography and response to the percutaneous coronary sinus-based mitral valve contour system

Rottländer D, Schneider T, Degen H, Laufenberg M, Chatrou M, Haude M

November 15, 2019 | 10.4244/EIJ-D-19-00054

Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) – Nice, France, 20-21 June 2018

Barbato E, Mauri Ferre J, Byrne RA, Roffi M, Fitzsimons D, Toth G, Capodanno D, Mehilli J, Petronio A, Chieffo A, Vardas P, Naber C, Dudek D, Haude M, Baumbach A

April 16, 2019 | 10.4244/EIJV14I17A297

Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina

Schueler R, Al-Lamee R, Mahfoud F, Capodanno D, Asnag M, Haude M

October 19, 2018 | 10.4244/EIJY18M09_2

Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds

Joner M, Ruppelt P, Zumstein P, Lapointe-Corriveau C, Leclerc G, Bulin A, Castellanos M, Wittchow E, Haude M, Waksman R

October 12, 2018 | 10.4244/EIJ-D-17-00708

Welcome to PCR London Valves 2018: 10th Anniversary Edition

Barbanti M, Prendergast B, Haude M, Piazza N, Windecker S, Baumbach A, Tamburino C

September 7, 2018 | 10.4244/EIJV14SABA1

Michael Haude

Latest news